Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series

by Telligen QI Connect™ | Oct 24, 2023

More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than 1 in 5 Medicare beneficiaries with an opioid use disorder diagnosis received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically during the transition of care.

This webinar series is a collaboration of all of the Quality Improvement Organizations and will provide strategies, interventions, and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

  • Register for this no-cost series here.

Session 1 – Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD (September 2023)

Emergency Physicians are active participants in the quest of solutions to identify patients at risk for substance abuse while using reasonable prescribing guidelines to address the legitimate pain reliefs needs of their patients. Learn how to recognize opioid use disorder, identify withdrawal, and initiate MOUD in the ED. Access the PowerPoint presentation and recording.

Session 2 – Role of the Pharmacist in the Treatment of Patients with OUD (October 2023)

Pharmacists play multiple roles for an effective opioid stewardship program. During this session, you will hear solutions to strengthen your medication process, how pharmacists lead and/or contribute to opioid stewardship program as well as how they address adverse drug events especially for patients with OUD. Access the PowerPoint presentation and recording.

Session 3 – Seamlessly Transitioning Patients on MOUD to Nursing Homes Part 1 (November 2023)

A well-planned transition of care ensures healthcare continuity, avoids preventable poor outcomes among patients with OUD and co-occurring mental health disorders. Challenges and barriers persist especially during the transfer of patients to nursing homes. During this two-part webinar, you will learn more from key actors that prepare the patient for discharge and communicate effectively with the receiving facility. Access the PowerPoint presentation and recording.

Session 4 – Seamlessly Transitioning Patients on MOUD to Nursing Homes Part 2 (January 2024)

In this webinar, we will delve deeper into effective strategies for safely transitioning patients on MOUD to nursing homes, exploring the essential steps in preparing patients for discharge. Key actors will share their successes to implement a strong partnership with post-acute care facilities and primary care physicians. Access the PowerPoint presentation and recording.

Session 5 – Management of Patients on MOUD During the Nursing Home Stay Part 1 (February 2024)

Nursing homes play a key role to ensure the continuity of MOUD after discharge from hospital by minimizing the risk of adverse events and promoting access to substance use disorders specialists and treatments as needed. During this 2-part webinar, you will learn more on how to include OUD screening in your admission assessment, provide access to treatment for patients with OUD, and how to recognize and manage a patient who is overdosing. Access the PowerPoint presentation and recording.

Session 6 – Management of Patients on MOUD During the Nursing Home Stay Part 2 (March 2024)

Access the PowerPoint presentation and recording.

Session 7 – Sustaining Recovery for Patients on MOUD Part 1 (April 2024)

Alternatives to Opioids (ALTO), peer support, NA meetings, counseling, and use of technologies. Access the PowerPoint presentation and recording.